This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bai, X.-F. Articles by Liu, Y. Search for Related Content PubMed PubMed Citation Articles by Bai, X.-F. Articles by Liu, Y.

On the Site and Mode of Antigen Presentation for the Initiation of Clonal Expansion of CD8 T Cells Specific for a Natural Tumor Antigen¹

Department of Pathology and Comprehensive Cancer Center, Ohio State University Medical Center, Columbus, Ohio 43210

Because of the low frequency of antigen-specific T cells, early events in the activation of tumor-specific T cells in vivo have not been well characterized. There is still no direct documentation on where the clonal expansion begins and how tumor antigens are presented to the host CD8 T cells to initiate it. Here we used transgenic T cells specific for a natural tumor antigen P1A to evaluate the kinetics, location, and modes of antigen presentation for initiating CTL response in vivo. Our results demonstrate that the initial activation of P1A-specific T cells takes place in the lymphoid organs. The activated T cells then migrate into tumors, where they undergo accelerated division and acquire distinct activation markers. The site of initiation cannot be altered by either local expression of costimulatory molecules or by intratumor injection of naïve T cells. Moreover, using genetic models that allow only one mode of antigen presentation, we show here that both cross-presentation of P1A by the host antigen-presenting cells, and direct antigen presentation and costimulation by the tumor cells are sufficient to initiate rapid T cell-clonal expansion in the lymphoid organ. These results provide direct evidence for two fundamental assumptions on the mechanisms of T-cell activation in vivo.

This article has been cited by other articles:

				P. Yu, Y. Lee, Y. Wang, X. Liu, S. Auh, T. F. Gajewski, H. Schreiber, Z. You, C. Kaynor, X. Wang, et al. Targeting the Primary Tumor to Generate CTL for the Effective Eradication of Spontaneous Metastases J. Immunol., August 1, 2007; 179(3): 1960 - 1968. [Abstract] [Full Text] [PDF]

				K. F. May Jr, K. Lute, E. Kocak, S. Abdessalam, L. Yin, O. Li, Z. Guan, G. Philips, P. Zheng, and Y. Liu Immune competence of cancer-reactive T cells generated de novo in adult tumor-bearing mice Blood, January 1, 2007; 109(1): 253 - 258. [Abstract] [Full Text] [PDF]

				K. M. Hargadon, C. C. Brinkman, S. L. Sheasley-O'Neill, L. A. Nichols, T. N. J. Bullock, and V. H. Engelhard Incomplete Differentiation of Antigen-Specific CD8 T Cells in Tumor-Draining Lymph Nodes J. Immunol., November 1, 2006; 177(9): 6081 - 6090. [Abstract] [Full Text] [PDF]

				X.-F. Bai, J.-Q. Liu, P. S. Joshi, L. Wang, L. Yin, J. Labanowska, N. Heerema, P. Zheng, and Y. Liu Different Lineages of P1A-Expressing Cancer Cells Use Divergent Modes of Immune Evasion for T-Cell Adoptive Therapy Cancer Res., August 15, 2006; 66(16): 8241 - 8249. [Abstract] [Full Text] [PDF]

				O. Li, X. Chang, H. Zhang, E. Kocak, C. Ding, P. Zheng, and Y. Liu Massive and destructive T cell response to homeostatic cue in CD24-deficient lymphopenic hosts J. Exp. Med., July 10, 2006; 203(7): 1713 - 1720. [Abstract] [Full Text] [PDF]

				K. Liu, J. Idoyaga, A. Charalambous, S.-i. Fujii, A. Bonito, J. Mordoh, R. Wainstok, X.-F. Bai, Y. Liu, and R. M. Steinman Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells J. Exp. Med., December 5, 2005; 202(11): 1507 - 1516. [Abstract] [Full Text] [PDF]

				S. R. Jenkinson, N. A. Williams, and D. J. Morgan The Role of Intercellular Adhesion Molecule-1/LFA-1 Interactions in the Generation of Tumor-Specific CD8+ T Cell Responses J. Immunol., March 15, 2005; 174(6): 3401 - 3407. [Abstract] [Full Text] [PDF]

				S. Roychowdhury, K. F. May Jr., K. S. Tzou, T. Lin, D. Bhatt, A. G. Freud, M. Guimond, A. K. Ferketich, Y. Liu, and M. A. Caligiuri Failed Adoptive Immunotherapy with Tumor-Specific T Cells: Reversal with Low-Dose Interleukin 15 but not Low-Dose Interleukin 2 Cancer Res., November 1, 2004; 64(21): 8062 - 8067. [Abstract] [Full Text] [PDF]

				J.-X. Gao, X. Chang, X. Zheng, J. Wen, L. Yin, P. Du, P. Zheng, and Y. Liu A new role for CD28 in the survival of autoreactive T cells in the periphery after chronic exposure to autoantigen Int. Immunol., October 1, 2004; 16(10): 1403 - 1409. [Abstract] [Full Text] [PDF]

				A. S. Yang, C. E. Monken, and E. C. Lattime Intratumoral Vaccination with Vaccinia-Expressed Tumor Antigen and Granulocyte Macrophage Colony-Stimulating Factor Overcomes Immunological Ignorance to Tumor Antigen Cancer Res., October 15, 2003; 63(20): 6956 - 6961. [Abstract] [Full Text] [PDF]

				X. Liu, J. X. Gao, J. Wen, L. Yin, O. Li, T. Zuo, T. F. Gajewski, Y.-X. Fu, P. Zheng, and Y. Liu B7DC/PDL2 Promotes Tumor Immunity by a PD-1-independent Mechanism J. Exp. Med., June 16, 2003; 197(12): 1721 - 1730. [Abstract] [Full Text] [PDF]

				P. Yu, M. T. Spiotto, Y. Lee, H. Schreiber, and Y.-X. Fu Complementary Role of CD4+ T Cells and Secondary Lymphoid Tissues for Cross-presentation of Tumor Antigen to CD8+ T Cells J. Exp. Med., April 21, 2003; 197(8): 985 - 995. [Abstract] [Full Text] [PDF]

				X.-F. Bai, J. Liu, K. F. May Jr, Y. Guo, P. Zheng, and Y. Liu B7-CTLA4 interaction promotes cognate destruction of tumor cells by cytotoxic T lymphocytes in vivo Blood, April 15, 2002; 99(8): 2880 - 2889. [Abstract] [Full Text] [PDF]